Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Satoshi Takakuwa"'
Autor:
Yasuhisa Ohata, Haruna Kakimoto, Yuko Seki, Yasuki Ishihara, Yukako Nakano, Kenichi Yamamoto, Shinji Takeyari, Makoto Fujiwara, Taichi Kitaoka, Satoshi Takakuwa, Takuo Kubota, Keiichi Ozono
Publikováno v:
Bone Reports, Vol 17, Iss , Pp 101637- (2022)
Pseudohypoparathyroidism 1A (PHP1A) and pseudopseudohypoparathyroidism (PPHP) are caused by loss-of-function variants of GNAS, which encodes Gsα. We present two unrelated Japanese families with PHP1A and PPHP harboring unreported pathogenic variants
Externí odkaz:
https://doaj.org/article/1bb2d9ce3da440dd8c935b6b42dd836e
Autor:
Satoshi Takakuwa, Nobuyuki Terasaki, Naochika Kon, Touyou Ohashi, Nobuyasu Nita, Yoshiyuki Nagatomo, Yoshirou Kuromitsu
Publikováno v:
Journal of Materials Science: Materials in Electronics. 33:10486-10493
Autor:
Shinji Takeyari1, Satoshi Takakuwa1,2 stakakuwa@hp.pref.hyogo.jp, Kei Miyata1, Kenichi Yamamoto1,3, Hirofumi Nakayama1,4, Yasuhisa Ohata1,5, Makoto Fujiwara1, Taichi Kitaoka1, Takuo Kubota1, Noriyuki Namba1,6, Norio Sakai1,7, Keiichi Ozono1
Publikováno v:
Clinical Pediatric Endocrinology. Jan2019, Vol. 28 Issue 1, p1-7. 7p. 2 Black and White Photographs, 1 Chart, 1 Graph.
Autor:
Satoshi Takakuwa, Kei Miyata, Yasuhisa Ohata, Takuo Kubota, Makoto Fujiwara, Kenichi Yamamoto, Norio Sakai, Taichi Kitaoka, Shinji Takeyari, Keiichi Ozono, Hirofumi Nakayama, Noriyuki Namba
Publikováno v:
Clinical Pediatric Endocrinology
Congenital generalized lipodystrophy type 4 (CGL4) is a rare disease caused by mutations in the gene polymerase I and transcript release factor (PTRF), the main symptoms of which are systemic reductions in adipose tissue and muscular dystrophy. The s
Autor:
Kunikazu Suzuki, Naotsune Hosono, Hiroko Akatsu, Satoshi Takakuwa, Wataru Toyoda, Naoki Hiki, Motohiro Ohkura
Publikováno v:
The Japanese Journal of Ergonomics. 53:65-74
Publikováno v:
Journal of the Japan Society of Powder and Powder Metallurgy. 64:355-358
Autor:
Noriyuki Namba, Takuo Kubota, Makoto Fujiwara, Satoshi Takakuwa, Yasuhisa Ohata, Makiko Tachibana, Yoko Miyoshi, Taichi Kitaoka, Kohji Miura, Wei Wang, Keiichi Ozono, Keiko Yamamoto, Hirofumi Nakayama
Publikováno v:
Clinical Endocrinology. 84:845-850
OBJECTIVE Serum amino-terminal propeptide of C-type natriuretic peptide (NT-proCNP) levels have been proposed as a biomarker of linear growth in healthy children. The usefulness of NT-proCNP in patients with achondroplasia (ACH)/hypochondroplasia (HC
Autor:
Satoshi Takakuwa1 okinawa.endocrinology@gmail.com, Yoko Kina1
Publikováno v:
Clinical Pediatric Endocrinology. Jan2014, Vol. 23 Issue 1, p17-25. 9p. 3 Charts, 4 Graphs.
Autor:
Yoko Kina, Satoshi Takakuwa
Publikováno v:
Clinical Pediatric Endocrinology
The initial treatment of childhood-onset Graves' disease is based on the result of clinical trials of adult-onset disease. The major adverse events associated with methimazole, the only medication approved for childhood-onset disease in Japan, are co
Autor:
Taichi Kitaoka, Makoto Fujiwara, Takuo Kubota, Keiko Yamamoto, Noriyuki Namba, Yasuhisa Ohata, Varoona Bizaoui-Auffret, Satoshi Takakuwa, Nobutoshi Nawa, Hirofumi Nakayama, Keiichi Ozono
Publikováno v:
Bone Abstracts.